Efficacy and Safety of LNP023 Compared With Rituximab in Subjects With Idiopathic Membranous Nephropathy
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB)
- Status
- WITHDRAWN
- Phase
- PHASE2
NKTR-255 in Relapsed/Refractory Multiple Myeloma & Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Trial to Compare Ibrutinib Versus Lenalidomide in Combination With MRE-chemotherapy for Adult Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL)
- Status
- RECRUITING
- Phase
- PHASE2
Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)
- Status
- COMPLETED
- Phase
- PHASE3
R2-MTX With Lenalidomide Maintenance in Newly-diagnosed PCNSL：a Multicenter Phase Ib/II Stuty
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Acalabrutinib Versus Chlorambucil Plus Rituximab in Adult Subjects With Previously Untreated Chronic Lymphocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Ibrutinib in Combination With Rituximab, in Japanese Participants With Waldenstrom's Macroglobulinemia (WM)
- Status
- COMPLETED
- Phase
- PHASE2
Ixazomib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Activity of Tiragolumab in Participants With Relapsed or Refractory Multiple Myeloma or With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
IVIG/Rituximab vs Rituximab in Kidney Transplant With de Novo Donor-specific Antibodies
- Status
- COMPLETED
- Phase
- PHASE4
Biomarker Guided Treatment in DLBCL
- Status
- UNKNOWN
- Phase
- PHASE2
FT516 in Subjects With Advanced Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Rituximab for HTLV-1-associated Myelopathy
- Status
- UNKNOWN
- Phase
- PHASE2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Rituximab in Participants With Refractory Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2